Amphetamine-Related Disorders: all 60 studies
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Psilocybin Therapy for Methamphetamine Use Disorder and HIVNot yet recruitingNCT07756736Phase 2
- Effects of Repetitive Transcranial Magnetic Stimulations in Patients With Amphetamine Use DisordersNot yet recruitingNCT06960265Not applicable
- Treatment Effect of Cross-frequency Transcranial Alternating Current Stimulation on the MUDRecruitingNCT06145698Not applicable
- Hospital-Based Contingency ManagementEnrolling by invitationNCT05515757Not applicable
- Change the Cycle: An RCT to Prevent Injection InitiationCompletedNCT02774954Not applicableResults posted
- Extended Release Naltrexone for Treating Amphetamine Dependence in IcelandCompletedNCT01100853Phase 3Results posted
- Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With MenCompletedNCT00856323Phase 2Results posted
- Study of Medical Treatment for Methamphetamine AddictionCompletedNCT00833443Phase 2Results posted
- An Assessment of the Safety of Varenicline in Methamphetamine-dependent VolunteersCompletedNCT00713479Phase 1Results posted
- A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or DependenceCompletedNCT00377299Not applicableResults posted
- Long-term Behavior Change - 1CompletedNCT00158197Not applicableResults posted
- Non-invasive Brain Stimulation in Patients With Methamphetamine Use DisorderStatus unknownNCT05535101Not applicable
- Preventing Parental Opioid and/or Methamphetamine Addiction Within DHS-Involved Families: PRE-FAIRCompletedNCT05380440Not applicable
- Repetitive Transcranial Magnetic Stimulation in Amphetamine AddictionCompletedNCT04993300Not applicable
- Psilocybin-Enhanced Psychotherapy for Methamphetamine Use DisorderActive, not recruitingNCT04982796Phase 1/2
- Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine AddictionStatus unknownNCT04687566Phase 2/3
- Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.Status unknownNCT04531384Not applicable
- Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment ModelStatus unknownNCT04203654Not applicable
- Computerized Exercise to Alter Stimulant Approach ResponsesStatus unknownNCT03902405Not applicable
- The Application of Cognitive Rehabilitation Therapy for Amphetamine-type Stimulants AddictionCompletedNCT03318081Not applicable
- The Application of Music Therapy in Female Amphetamine Use DisorderCompletedNCT03221283Not applicable
- Cannabioids as a New Intervention for Amphetamine DependenceWithdrawnNCT02952196Phase 2
- The Novel Addiction Assessment Study in Synthetic Drugs AddictionCompletedNCT02950376
- Conflict Between Maternal Autonomy and Child Health in Substance-useCompletedNCT02797990
- Novel Intervention for Amphetamine-type Stimulants AddictionCompletedNCT02713815Not applicable
- Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in MalaysiaStatus unknownNCT02541526Phase 3
- An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS DependenceStatus unknownNCT02541513Phase 3
- An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS DependenceStatus unknownNCT02541500Phase 3
- Mephedrone and Alcohol Interactions in HumansCompletedNCT02294266Phase 1
- The Diagnostic Assessment and Intervention Study of Amphetamine Type StimulusCompletedNCT02285556Not applicable
- Abuse Liability and Human Pharmacology of MephedroneCompletedNCT02232789Phase 1
- A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine DependenceStatus unknownNCT01899313Not applicable
- Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0)CompletedNCT01888835Phase 2
- Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM)CompletedNCT01449565Phase 2
- Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA)CompletedNCT01386177Phase 1
- Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET ImagingCompletedNCT01296802Not applicable
- Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/DependenceStatus unknownNCT01273701Not applicable
- Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA)CompletedNCT01270672Not applicable
- Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)CompletedNCT01136278Phase 1
- Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)CompletedNCT00990067Phase 1
- Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine)CompletedNCT00895804Phase 1
- Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)CompletedNCT00886886Phase 1
- A Dose Ranging Study of Modafinil for Methamphetamine DependenceStatus unknownNCT00630097Phase 2
- Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and RewardWithdrawnNCT00600145Not applicable
- A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1Status unknownNCT00267657Phase 1
- Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1Status unknownNCT00265278Phase 1
- Functional Brain Imaging in Recreational Users of EcstasyCompletedNCT00254306
- Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant AbuseCompletedNCT00248092Phase 1/2
- Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse HistoriesCompletedNCT00247572Phase 2
- Trial of Modafinil for Methamphetamine DependenceStatus unknownNCT00123370Phase 2
- To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1Status unknownNCT00100074Phase 1
- Assessment of Interactions Between Methamphetamine and Aripiprazole - 1Status unknownNCT00089440Phase 1
- Bupropion for the Treatment of Methamphetamine Dependence - 1CompletedNCT00069251Phase 2
- Ondansetron for the Treatment of Methamphetamine Dependence - 1CompletedNCT00040053Phase 2
- Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1Status unknownNCT00040040Phase 1
- Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Status unknownNCT00033072Phase 1
- Cognitive Correlates of Substance Abuse, Part 2 - 16Status unknownNCT00000351
- Effects of Stimulant Dependence on Human Striatal Dopamine System - 15Status unknownNCT00000350Phase 1
- Cognitive Correlates of Substance Abuse - 11Status unknownNCT00000346Phase 4
- Tyrosine for Methamphetamine Dependence - 1CompletedNCT00000322Phase 2